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Edited by Jesus AvilaAbstract Allergen-induced airway inﬂammation may lead to
allergic asthma, a chronic inﬂammatory disease of the respira-
tory system. Despite its high incidence, the majority of the
world’s population is unaﬀected by allergic airway inﬂammation
most likely due to innate protective mechanism(s) in the respira-
tory system. The mammalian airway epithelia constitutively ex-
press uteroglobin (UG), a protein with potent anti-inﬂammatory
and anti-chemotactic properties. We report here that UG binds
to FPR2, a G-protein coupled receptor, inhibits chemotaxis,
down-regulates SOCS-3 gene expression and STAT-1 activa-
tion, which are critical for the diﬀerentiation of T-helper 2
(TH2) cells that secrete pro-inﬂammatory TH2 cytokines. We
propose that UG suppresses allergen-mediated activation of
TH2 response by down-regulating the expression of genes that
are critical for TH2 diﬀerentiation.
Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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During the past two decades, the incidence of allergen-in-
duced airway inﬂammation, one of the leading causes of aller-
gic asthma, has nearly doubled [1]. Interestingly, despite this
high incidence the majority of the world’s population manages
to remain free of this chronic airway inﬂammatory disease.
Innate mechanisms may exist to suppress allergen-induced
inﬂammatory response in the airways and to maintain homeo-
stasis in the respiratory system. Accumulating evidence indi-
cates that a complex interplay of genetic and environmental
factors contributes to the onset and maintenance of allergen-
mediated airway inﬂammation in allergic asthma [2]. In this
scenario, cytokines secreted by T helper-2 (TH2) cells, such asAbbreviations: UG, uteroglobin; UG-KO, uteroglobin-knockout;
CC10, Clara cell 10 kDa protein; OVA, ovalbumin; SAA, serum
amyloid A; FPR, formyl peptide receptor; TH2 cells, T-helper 2 cells;
DCs, dendritic cells; SOCS-3, suppressor of cytokine signaling-3
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[2]. More speciﬁcally, it has been reported that the presence of
IL-4 during the initiation phase of allergic inﬂammatory re-
sponse leads to the diﬀerentiation and predominance of TH2
cell lineage that elaborate pro-inﬂammatory TH2 cytokines.
Dendritic cells (DCs), themajor antigen presenting cells in the
body, play pivotal roles in the diﬀerentiation of TH2 cell lineage
from naı¨ve CD4+ T cells [2]. Upon encountering antigen(s), the
DCs process the antigen and migrate to the lymphatic system to
present the processed antigen to naı¨ve T cells and regulate the
diﬀerentiation as well as activation of antigen-speciﬁc TH2 cells
[3]. Recently, it has been shown that suppressor of cytokine sig-
naling-3 (SOCS-3) plays critical regulatory roles in the initiation
and maintenance of TH2-mediated allergic airway inﬂamma-
tory responses [4], which are mediated by TH2 cytokines. Con-
sistent with these ﬁndings, SOCS-3 over-expression has been
shown to play a critical role in the diﬀerentiation of the TH2 cell
lineage and the maintenance of TH2 predominance [4].
Uteroglobin (UG) or Clara cell 10 kDa protein (CC10) is the
founding member of the newly recognized Secretoglobin super-
family. It is a steroid-inducible secreted protein, which is con-
stitutively expressed at a high level by the airway epithelial cells
of all mammals and possesses potent anti-chemotactic and
anti-inﬂammatory properties [5]. We recently reported that
UG-knockout (UG-KO) mice [6], sensitized and challenged
with a model allergen, ovalbumin (OVA), manifest exagger-
ated inﬂammatory response in the airways mediated by
elevated levels of TH2 cytokines and eotaxin, which are charac-
teristically found in allergic asthma [7]. Several years ago, we
reported that UG inhibits chemotaxis of monocytes and
neutrophils induced by a potent chemoattractant peptide,
fMLP [8]. It is now known that chemoattraction by fMLP is
mediated via a family of G-protein coupled receptors known
as formyl peptide receptors (FPRs) reviewed in [9]. Interest-
ingly, among the two isoforms of FPR, fMLP binds to FPR
with high aﬃnity while it manifests low aﬃnity for binding
to FPR2 (FPRL1R in human) [10].
Antigen (allergen) exposure to the respiratory system
stimulates the expression of acute phase proteins such as serum
amyloid A (SAA) [11]. It has been reported that dendritic cells
(DCs), which are the major antigen presenting cells (APCs),
express FPR2 [12] that promotes SAA-binding on these cells
[13]. Thus, interaction of SAAwithFPR2onDCsmay stimulate
chemotacticmigration of theseAPCs to the antigen site facilitat-
ing the processing and presentation of antigens. Recently, it has
been shown that the direction of TH2 diﬀerentiation, whichEuropean Biochemical Societies.
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environment at the site of initial antigenic (allergic) activation
[4].
To determine the molecular mechanism(s) by which UG
suppresses allergen-induced TH2 cytokine production that
causes airway inﬂammation, we used UG-KO mice and stud-
ied the expression of genes that are critically important in
the diﬀerentiation of TH2 cell lineage. Our results demonstrate
that UG binds to FPR2 inhibits chemotaxis, down-regulates
SOCS-3 gene expression and STAT-1 activation, which are re-
ported to play critical roles in the diﬀerentiation of TH2 cells.A BSAA-mRNA levels(basal)
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Fig. 1. A. Expression of SAA-3 mRNA in non-sensitized and un-
challenged WT (bar1) and non-sensitized and un-challenged UG-KO
(bar 2) mice. Real time PCR using total RNA from the lungs was used
to determine the mRNA levels; B. Expression of SAA-mRNA in WT
(bar 1) and UG-KO (bar 2) mice sensitized and challenged with OVA
by real time quantitative PCR. Note the level of SAA-mRNA in OVA-
sensitized and challenged UG-KO mice is signiﬁcantly higher
(p < 0.05) compared with that of the WT mice (n = 3).2. Materials and methods
2.1. Materials
Chicken OVA (grade V), protease inhibitor mixture, phosphatase
inhibitor mixture were from Sigma; puriﬁed human serum amyloid
A (SAA) from Peprotech Inc. (Rocky Hill, NJ); Pre-cast SDS–poly-
acrylamide (4–15%) gels from Bio-Rad; antibodies to SOCS-3 (Novus
Biologicals); STAT-1, phospho-Ser-STAT-1, phospho-Tyr-STAT-1
(Cell Signaling) and horseradish peroxidase (HRP)-conjugated donkey
anti-rabbit IgG are from Santa Cruz.
2.2. Mice
UG-KO mice were generated as described previously [6]. Both UG-
KO and WT mice were maintained under germ-free conditions and all
experiments were performed according to a protocol approved by the
NICHD Animal Care and Use Committee. Airway inﬂammation by
OVA is induced as previously reported [7].
2.3. Cytokine array
Cytokine levels in sera from both WT and UG-KO mice were deter-
mined using Mouse Cytokine ArrayII from Ray Biotech, Inc. (Nor-
cross, GA) following the vendor’s protocol.
2.4. Isolation of RNA and real-time PCR
Total RNA from the lungs was isolated by TriZol (In Vitrogen)
method and real-time PCR was performed using ABI Prism 7000 Se-
quence Detection System (Applied Biosystems) as described previously
[7]. The primers used are: SOCS-3 (sense 5 0TTG TCT CTC CTA TGT
GGG GC and antisense 5 0TGT GTT TGG CTC CTT GTG TG),
STAT-1 (sense 5 0CTT GAC GAC CCT AAG CGA AC and antisense
5 0 GCA GGT TGT CTG TGG TCT GA), FPR-2 (sense 5 0TGG CTG
GTT CCT GTG TAA AT and antisense 5 0CCA AGG CAA TGA
GAG CAA TC), SAA-3 (sense 5 0GAA GCC TTC CAT TGC CAT
CA and antisense 5 0CCCT TGA CCA GCT TCT TTC ATG) and
b-Actin (sense 5 0ACG GCC AGG TCA TCA CTA TTG, and anti-
sense 5 0TGG AAA AGA GCC TCA GGG C). The data from each
PCR run were analyzed using ABI Prism Software version 1.01 (Ap-
plied Bios stems). The ﬁnal data were normalized to b-Actin and pre-
sented as fold increase compared with the expression level in WT mice.
Quantization was performed using three independent total RNA sam-
ples for each treatment group. The results are presented as the means
(n = 3) ± S.D.
2.5. Western blot analysis
Lung lysates (20–30 lg total protein) were resolved by SDS–PAGE
and analyzed by Western blotting as previously described [7] using
1:1000 dilution of antibodies to the following proteins: SOCS-3;
STAT-1, phospho-S-STAT-1and phospho-Y- STAT-1. The secondary
antibody, HRP-conjugated donkey anti-rabbit IgG, was diluted
1:10000. Chemiluminescent protein bands were detected by an ECL
detection system (Amersham Biosciences) according to the manufac-
turer’s protocol.
2.6. Migration of mL4-7 cells in response to SAA
mL4-7 cells were generated by stably transfecting HEC-293 cells
with a mouse FPR-2-cDNA construct as previously described [11].
Migration of mL4-7 cells were performed using BD Biocoat MatrigelInvasion chambers, following the manufacturer’s protocol. Brieﬂy,
0.5 ml of 5 · 104 cells/ml were added in absence and presence of 10–
200 nM of UG to the insert and 1 ml of cell culture medium containing
1 lM SAA was added to each well. Myoglobin (MG; 200 nM) was
used as a non-speciﬁc protein control for UG and the cells were
cultured for 72 h at 37 C and cells were stained as per standard pro-
tocol.2.7. Binding studies
Binding of 3H-UG to HEK-293 and mL4-7 cells was carried out
according to a protocol described previously [14]. The data were ana-
lyzed by using graph Pad Prism version 4.1 to determine the dissocia-
tion constant (Kd) for each ligand.3. Results
3.1. Allergen exposure induces elevated serum amyloid A
expression in the lungs of UG-KO mice
Since DCs are the major antigen (allergen)-presenting cells
and SAA is reported to be a chemoattractant for DCs, we ﬁrst
sought to determine whether antigenic exposure to UG-KO
mice induces elevated levels of SAA-mRNA in the lungs.
Accordingly, we sensitized and challenged UG-KO mice and
their WT littermates with OVA. The results show that the
basal levels of SAA-mRNA in the lungs of the UG-KO mice
are appreciably higher than those in the lungs of WT litter-
mates (Fig. 1A). However, while OVA-sensitization and chal-
lenge stimulates SAA-mRNA expression in both groups of
mice the level of expression in the UG-KO lungs is still mark-
edly higher (Fig. 1B). We also determined the FPR2-mRNA
levels by real time PCR using total RNA from the lungs of
UG-KO mice and from those of their WT littermates. The re-
sults show that the FPR2-mRNA expression in the lungs of
UG-KO mice is markedly higher compared with that of their
WT littermates (data not shown). Taken together, these results
indicate that UG-KO mice may be more susceptible to aller-
gen-induced production of SAA, which has been reported to
provide chemotactic signal for the migration of the DCs.
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speciﬁcity
Several years ago, we reported that UG is a potent inhibitor
of fMLP-induced chemotaxis of monocytes and neutrophils
[8]. However, at that time fMLP receptors were not identiﬁed
by molecular cloning and characterization. Since SAA binds to
FPR2 on DCs [12] and stimulates migration of these cells, we
sought to determine whether UG may interact with FPR2 and
compete with SAA for binding to this receptor, thereby inhib-
iting the migration of the DCs to the antigen site essential for
antigen processing. Because pure cultures of DCs are diﬃcult
to obtain, we performed binding assays using [125I]-SAA and
[3H]-UG on mL4-7 cells [13], which are generated by stably
transfecting HEK-293 cells with a FPR2-cDNA construct.
The results show that while HEK-293 cells, without FPR2-
cDNA transfection (control), do not bind SAA or UG (data
not shown), mL4-7 cells manifest saturable binding of both
ligands (Fig. 2A and B). However, while the dissociation con-
stant (Kd) for SAA binding to FPR2 is 292 nM (Fig. 2A) that
of UG is 33 nM (Fig. 2B) suggesting a slightly higher aﬃnity of
FPR2 for UG. We then tested the speciﬁcity of UG-binding on
FPR2 by conducting a [3H]-UG binding assay in which non-
radioactive UG was used as the competing ligand. The results
show that while HEK-293 cells do not interact with 3H-UG,
the mL4-7 cells readily bind this ligand and in a competition
assay, it is displaced by non-radioactive UG in a dose-depen-
dent manner (data not shown). Taken together, these results
suggest that UG binds to FPR2 with high speciﬁcity and it ap-0 250 500 750 1000 1250
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Fig. 2. Saturation isotherms of [125I]-SAA (A) and [3H]-UG (B) on
mL4-7 cells. Note a slightly higher dissociation constant (Kd) for
125I-SAA compared to that of 3H-UG.pears to have a slightly higher aﬃnity for binding to FPR2
than that of SAA. Thus, UG may have the potential to eﬀec-
tively compete with SAA, a known chemoattractant for DCs
[12]. It should be noted here that there are many known li-
gands of FPR2 [15], however, UG is one of the few ligands
that binds to this receptor with high aﬃnity. Most interest-
ingly, while most ligands of FPR2 are agonists, UG appears
to be an antagonist of this receptor.
3.3. UG inhibits SAA mediated migration of cells expressing
FPR2
To determine whether the binding of UG with FPR2 may
prevent SAA-mediated chemotactic migration of mL4-7 cells,
we performed migration assays using SAA as the chemoattrac-
tant and UG as the competing ligand. The non-transfected
HEK-293 cells, which do not express FPR2, served as controls.
The results show that while SAA does not stimulate the che-
motactic migration of HEK-293 cells, it readily induces migra-
tion of mL4-7 cells (Fig. 3, upper row). Most importantly, UG
appears to strongly inhibit SAA-mediated chemotactic migra-
tion of mL4-7 cells in a dose-dependent manner (Fig. 3, upper
and lower rows). We used myoglobin (MG) as a non-speciﬁc
protein control for UG and the results show that it has no
inhibitory eﬀect on SAA-mediated chemotactic migration of
mL4-7 cells (Fig. 3, lower row). Moreover, while 1 lM SAA
mediates strong chemotactic migration of mL4-7 cells, such
migration is inhibited by nM concentrations of UG in a
dose-dependent manner. Since DCs express FPR2 and SAA
mediates chemotactic migration of the DCs our results imply
that UG-mediated suppression of SAA-induced migration of
these cells may be due to the competition between the two pro-Fig. 3. Inhibition of SAA-induced migration of mL4-7 cells by UG.
Note while UG inhibits SAA-induced migration of mL4-7 cells in a
dose-dependent manner and myoglobin (MG), even at a concentration
of 200 nM, does not appear to inhibit migration of these cells.
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migration is likely to interfere both with the recruitment of
DCs to the antigen site as well as with antigen presentation
to naı¨ve T cells, thereby suppressing the diﬀerentiation of
TH2 cells.
3.4. UG inhibits SOCS-3 expression
Recently, it has been reported that suppressor of cytokine
signaling-3 (SOCS-3) regulates the initiation and maintenance
of TH2-mediated allergic responses [4]. We previously demon-
strated that the basal levels of TH2 cytokines in UG-KO mice
are higher compared with those of their WT littermates [7].
Moreover, OVA-sensitization and challenge of the UG-KO
mice augment these levels even further. Thus, we sought to
determine the levels of SOCS-3 gene expression in the lungs
of UG-KO mice and in those of their WT littermates with or
without OVA-sensitization and challenge. The results show
that while low levels of SOCS-3 mRNA (Fig. 4A, bar 1) and
SOCS-3 protein (Fig. 4B, lane 1) are expressed in the lungs
of WT mice, these levels are appreciably higher in their UG-β
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Fig. 4. A. Expression of SOCS-3 was determined by quantitative real
time PCR using total RNA from the lungs of WT (bar 1), OVA-
sensitized and challenged WT (bar 2), UG-KO (bar 3), OVA-sensitized
and challenged UG-KO (bar 4), and, OVA-sensitized UG-KO mice
pretreated with recombinant UG (rUG) prior to OVA challenge (bar
5); B. Detection of SOCS-3 protein by Western blot analysis using total
protein extracted from the lungs of WT (lane 1), OVA sensitized and
challenged WT (lane 2), UG-KO (lane3), OVA sensitized and
challenged UG-KO (lane 4), and OVA sensitized UG-KO mice
pretreated with rUG before OVA challenge (lane 5); C. UG inhibits
OVA-induced expression and activation of STAT-1. Expression of
STAT-1 mRNA was determined by quantitative real time RT-PCR
using total RNA from lungs of WT(bar 1), OVA sensitized and
challenged WT (bar 2), UG-KO (bar 3), OVA sensitized and
challenged UG-KO (bar 4), and, OVA sensitized UG-KO mice
pretreated with rUG before OVA challenge (bar 5). D. Detection of
STAT-1 protein and phosphorylation of tyrosine on STAT-1 (p-Y-
STAT-1) and phosphorylation of serine on STAT-1 (p-S-STAT-1) by
Western blot analysis using total protein extracted from WT (lane1),
OVA sensitized and challenged WT (lane 2), UG-KO (lane 3), OVA-
sensitized and challenged UG-KO (lane 4), and OVA-sensitized UG-
KO mice pretreated with rUG before OVA challenge (lane 5).KO littermates (Fig. 4A, bar 3 and B, lane 3). Moreover,
OVA-sensitization and challenge elevated the expression of
SOCS-3-mRNA albeit slightly (Fig. 4A, bar 2) and SOCS-3-
protein (Fig. 4B, lane 2) in the lungs of WT littermates. Most
importantly, in the lungs of OVA-sensitized and challenged
UG-KO mice the SOCS-3 mRNA (Fig. 4A, bar 4) and
SOCS-3 protein (Fig. 4B, lane 4) levels are markedly aug-
mented. Notably, these high levels of SOCS-3 mRNA and pro-
tein are drastically suppressed when OVA-sensitized UG-KO
mice are treated with puriﬁed recombinant UG prior to
OVA-challenge (Fig. 4A, bar 5 and B, lane 5). These results
strongly suggest that UG suppresses OVA-induced stimulation
of SOCS-3 expression in the lungs, and most likely, down-reg-
ulates this critical step in the pathway of allergen-mediated dif-
ferentiation of TH2 cells [4].3.5. UG suppresses allergen-induced SOCS-3 expression by
inhibiting STAT-1 activation
How might UG suppress SOCS-3 expression? It has been
reported that the 5 0-promoter region of the SOCS-3 gene
contains binding motifs for signal transducer and activator
of transcription-1 (STAT-1) and STAT-1 activation has been
shown to play a critical role in SOCS-3 gene expression [4].
Accordingly, we determined the expression of STAT-1 in the
lungs of WT and UG-KO mice before and after OVA-sensiti-
zation and challenge. The results show that there is virtually no
diﬀerence in the basal levels of STAT-1 mRNA in the lungs of
WT (Fig. 4C, bar 1) and UG-KO mice (Fig. 4C, bar 3). How-
ever, while in the WT mice OVA-sensitization and challenge
made virtually no diﬀerence in the STAT-1 mRNA level
(Fig. 4C, bar 2), in the UG-KO mice OVA-sensitization and
challenge strikingly increased the level of STAT-1 mRNA
(Fig. 4C, bar 4). Most interestingly, the level of STAT-1
mRNA in the lungs of OVA-sensitized UG-KO mice is dra-
matically reduced when they were treated with recombinant
UG prior to OVA-challenge (Fig. 4C, bar 5). These results sug-
gest that UG is an eﬀective inhibitor of OVA-induced STAT-1
mRNA expression.
Phosphorylation of serine and tyrosine residues on STAT-1
plays critical roles in its activation. Thus, we ﬁrst sought to
determine the eﬀect of OVA-sensitization and challenge on
STAT-1 phosphorylation in the lungs of UG-KO mice and
their WT littermates and the eﬀect of UG treatment of UG-
KO mice on STAT-1 phosphorylation. Accordingly, we ﬁrst
performed Western blot analyses of lung lysates from WT
and UG-KO mice before and after OVA-sensitization and
challenge using phosphoserine- and phosphotyrosine-antibod-
ies. We also determined the eﬀect of UG-treatment on STAT-1
phosphorylation. Our results show that there is virtually no
change in the levels of serine- and tyrosine-phosphorylation
of STAT-1 in the lungs of control WT and UG-KO mice
(Fig. 4D, lanes 1 and 3). However, while a slightly increased
level of serine- as well as tyrosine-phosphorylation on STAT-
1 is appreciable in OVA-sensitized and challenged WT mouse
lungs (Fig. 4D, lane 2), such levels are markedly elevated in
those of the UG-KO mice sensitized and challenged with
OVA (Fig. 4D, lane 4). Most importantly, these high levels
of phosphorylated STAT-1 were dramatically reduced when
OVA-sensitized UG-KO mice were treated with recombinant
UG prior to OVA-challenge (Fig. 4D, lane 5). These results
strongly suggest that UG suppresses SOCS-3 gene expression
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and phosphorylation (activation) of STAT-1.4. Discussion
We previously reported that UG-KO mice manifest OVA-
induced exaggerated airway inﬂammatory response mediated
by TH2 cytokines, which are produced by TH2 cells. However,
the molecular mechanism(s) by which UG suppresses the pre-
dominance of TH2 cells until now remained unclear. In this
study we show that UG binds to FPR2, a G-protein coupled
receptor known to be expressed on antigen-presenting DCs,
inhibits chemotaxis, down-regulates SOCS-3 gene expression
and STAT-1 activation, all of which play critical roles in
TH2 diﬀerentiation. These results imply that UG promotes
allergen-induced TH2 predominance by suppressing the expres-
sion of genes that are known to play critical roles in TH2 dif-
ferentiation and predominance.
Recently, it has been reported that IL-12p40 is required for
the migration of DCs [16], which plays critical roles in the dif-
ferentiation, antigen presentation and maintenance of TH2
predominance. It has also been reported that while IL-12p70
promotes the diﬀerentiation of TH1 cells, IL-12 p40 in the pres-
ence of IL-4 acts as an antagonist of IL-12p70. As a result,
elevated IL-12p40 production suppresses TH1 diﬀerentiation,
thereby allowing TH2 predominance. We have previously re-
ported that UG-KO mice have elevated levels of IL-4 expres-
sion [7]. Therefore, we determined IL-12p40 and IL-12p70
levels in the sera of UG-KO and WT mice, respectively, by ser-
um protein microarray analysis. The results show that while in
the sera of UG-KO mice IL-12p40 is readily detectable; it is
virtually undetectable in those of the WT littermates (data
not shown). Interestingly, no appreciable diﬀerence in the ser-
um levels of IL-12p70 between UG-KO and WT mice were
found (data not shown). Since IL-12p40 inhibits the diﬀerenti-
ation of TH1 cells and it is present in the sera of UG-KO mice
but not in those of their WT littermates, our results suggest
that under physiological conditions one of the functions of
UG is to suppress TH2 predominance and maintain homeosta-
sis in the respiratory system.
Allergen-mediated airway inﬂammation leads to allergic
asthma, a chronic airway inﬂammatory disease, the incidence
of which continues to rise throughout the industrial world.
In the US alone, more than 6000 deaths occur annually from
complications of asthma. Insight into the molecular mecha-
nisms of pathogenesis of allergen-mediated airway inﬂamma-
tion may facilitate the development of novel and rational
therapeutic approaches to this common disease. The results
of our present study demonstrate for the ﬁrst time that one
of the important roles of UG is to down-regulate some of
the molecular events critical for the diﬀerentiation of TH2 cells.
These results also provide the proof of principle that recombi-
nant UG is a potential drug target for the development of no-
vel therapeutic approaches to allergen-mediated inﬂammatory
diseases.
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